ERK Mutations Confer Resistance to Mitogen-Activated Protein Kinase Pathway Inhibitors

2014

Identification of ERK1/2 mutations may provide insights for resistance to therapies targeting this pathway

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

36

References

71

Citations